Milena Filipova

Yulia Nedelcheva


The purpose of the study is to determine the competitiveness of pharmaceutical manufacturers in Bulgaria in unique environment of COVID-19 pandemic. The focus of the study is to fix the main factors that determine competitiveness. Achieving this purpose will form a better understanding of functioning of the pharmaceutical industry, as well as the possibility to take corrective action through recommendations and identify untapped opportunities to increase competitiveness. The results of the study determine two main factors for the competitiveness of pharmaceutical manufacturers – the quality and the price of pharmaceutical products. The leading place of quality as factor defines the manufacturing of pharmaceutical products mainly as part of healthcare system and at next place – as part of the economy. The conclusions reached are crucial in defining the purpose of pharmaceutical policy for safe, effective and affordable pharmaceutical products.

Keywords: Bulgaria; SWOT analysis; Porter's five forces analysis 

JEL Codes: D22; I11; L11


Borisova, L. (2017). Balanced Scorecard in the Organization. Entrepreneurship, V(1), 66-76.

Gergova, V., Stoimenova, A. & Sidjimova, D. (2019). Reporting of Clinical Trials on Medicinal Products – Regulations and Practices in EU. Health Policy and Management, 19(4), 53-57.

Ilieva-Tonova, D., Stoimenova, A. & Pencheva, I. (2016). Market Surveillance and Control of Medicinal Products in Bulgaria 2009 – 2015. Science & Technologies, VI(1), 365-373.

Ilieva-Tonova, D., Pencheva, I. & Serbezova, A. (2022). HPLC Tests in Quality Control under the Market Surveillance Program for Medicinal Products Containing Amlodipine and Valsartan. Current Pharmaceutical Analysis, 18. https://doi.org/10.2174/1573412917666210830130029

Keremidchiev, Sp. & Nedelchev, M. (2022). Corporate Governance Assessment of State-Owned Hospitals. Bulgarian Journal of Public Health, 14(1), 3-14.

Madgerova, R. & Kyurova, V. (2014). Definition, characteristics and problems of family business. Economics and Management, X(2), 97-105.

Nedelchev, M. (2019). Corporate Governance of State-Owned Enterprises: the Case of Healthcare Establishments in Bulgaria. Economic Studies, 1, 115-123. https://doi.org/10.2139/ssrn.3398824

Nedeltchev, Dr. (2005). Social capital and economic development. Sofia: Akademichno izdatelstvo Marin Drinov.

Petrova, G. (2018). Some New Pharmacologic Options for Open-Angle Glaucoma. World Journal of Pharmacy and Pharmaceutical sciences, 6, 29.

Stoimenova, A., Kirilov, B. & Zaykova, K. (2019). Analysis of Good Distribution Practice Inspection Deficiency Data of Pharmaceutical Wholesalers in Bulgaria. Pharmacia, 66(3), 85-89. https://doi.org/10.3897/pharmacia.66.e35880

Yuleva, R. (2019). Competitive Advantages and Competitive Strategies of Small and Medium-Sized Enterprises. Economics and Management, XVІ(1), 71-81.

Full text: PDF (English)

To cite this article: FILIPOVA M., Y. NEDELCHEVA (2022). Competitiveness factors of pharmaceutical manufacturer. Entrepreneurship, 10 (1), 78-92 DOI: 10.37708/ep.swu.v10i1.8